Vesicular Drug Delivery Systems: Promising Approaches in Ocular Drug Delivery
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(4), P. 511 - 511
Published: April 16, 2024
Ocular
drug
delivery
poses
unique
challenges
due
to
the
complex
anatomical
and
physiological
barriers
of
eye.
Conventional
dosage
forms
often
fail
achieve
optimal
therapeutic
outcomes
poor
bioavailability,
short
retention
time,
off-target
effects.
In
recent
years,
vesicular
systems
have
emerged
as
promising
solutions
address
these
challenges.
Vesicular
systems,
such
liposome,
niosome,
ethosome,
transfersome,
others
(bilosome,
transethosome,
cubosome,
proniosome,
chitosome,
terpesome,
phytosome,
discome,
spanlastics),
offer
several
advantages
for
ocular
delivery.
These
include
improved
prolonged
time
on
surface,
reduced
systemic
side
effects,
protection
drugs
from
enzymatic
degradation
dilution
by
tears.
Moreover,
formulations
can
be
engineered
targeted
specific
tissues
or
cells,
enhancing
efficacy
while
minimizing
They
also
enable
encapsulation
a
wide
range
molecules,
including
hydrophilic,
hydrophobic,
macromolecular
drugs,
possibility
combination
therapy
facilitating
co-delivery
multiple
drugs.
This
review
examines
their
over
conventional
production
techniques,
applications
in
management
diseases.
Language: Английский
Solubility determination, correlation, solvent effect and thermodynamic properties of tolnaftate in ten mono-solvents and binary solvent systems from 283.15 K to 328.15 K
Kejia Wang,
No information about this author
Wei Zhang,
No information about this author
Yuanmo Ren
No information about this author
et al.
The Journal of Chemical Thermodynamics,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107468 - 107468
Published: Feb. 1, 2025
Language: Английский
PEGylated terpesomes of curcumin for prominent hepatoprotective activity: fabrication, optimization, biochemical analysis and in vivo evaluation
Journal of Drug Delivery Science and Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106876 - 106876
Published: April 1, 2025
Language: Английский
Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.
International Journal of Pharmaceutics X,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100333 - 100333
Published: April 1, 2025
Herein,
we
investigated
the
preparation
and
characterization
of
Terconazole
loaded
edge-activated
hybrid
elastosome
(TCN-EHE)
adopting
thin
film
hydration
technique
for
treatment
ocular
mycosis.
(TCN)
is
a
broad
spectrum
antimycotic
agent
suffering
from
sparse
aqueous
solubility
impeding
its
use
in
ophthalmic
preparations.
The
scrutinized
formulation
variables
namely
X1:
Surfactant:
Edge
activator
ratio
(SAA:
EA),
X2:
Pluronic®
L121
contribution
(%
total
SAA)
X3:
EA
concentration
(%w/v)
were
optimized
D-optimal
design.
Ten
runs
prepared
characterized
regarding
their
entrapment
efficiency,
particle
size,
polydispersity
index
zeta
potential.
An
formula
was
generated,
with
high
desirability,
exhibited
satisfactory
nanoscaled
size
aligning
TEM,
plausible
potential
bi-phasic
release
pattern
which
not
altered
after
short-term
storage.
TCN-EHE
displayed
1.94-fold
enhanced
ex-vivo
corneal
permeation
flux.
Safety
ratified
through
measured
level,
pH
histopathological
evaluation.
In-vivo
uptake
visualized
by
confocal
laser
microscopy
demonstrated
2.7-fold
deeper
penetration.
Moreover,
Superior
antifungal
activity
has
been
displaying
37
%
bigger
zone
inhibition,
8-fold
lower
minimum
inhibitory
fungal
alongside
significantly
higher
biofilm
inhibition
at
all
tested
concentrations
compared
to
TCN
suspension.
Conclusively,
could
prospect
that
might
be
revamped
therapeutic
alternative
delivery
poorly
soluble
agents
combat
Language: Английский
ENHANCING QUALITY-BY-DESIGN THROUGH WEIGHTED GOAL PROGRAMMING: A CASE STUDY ON FORMULATION OF ULTRADEFORMABLE LIPOSOMES
Drug Development and Industrial Pharmacy,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 28
Published: Feb. 24, 2025
Introduction
Optimization
of
pharmaceutical
formulations
requires
advanced
tools
to
ensure
quality,
safety,
and
efficacy.
Quality-by-Design
(QbD),
introduced
by
the
FDA,
emphasizes
understanding
controlling
processes
early
in
development.
Advanced
optimization
methods,
such
as
desirability,
have
surpassed
traditional
single-objective
techniques.
Others
Weighted
Goal
Programming
(WGP)
offers
unique
advantages
integrating
decision-maker
preferences,
enabling
balanced
solutions
for
complex
drug
delivery
systems.
This
study
applies
WGP
optimize
timolol-loaded
nanoliposomes
aligning
with
QbD
principles.
Language: Английский